<!doctype html public "-//IETF//DTD HTML//EN">
<HTML>
<HEAD>
<TITLE>Converted by EDGARwiz</TITLE>
<META NAME="author" CONTENT="W. R. Eilers">
<META NAME="date" CONTENT="07/30/2014">
</HEAD>
<BODY style="line-height:12pt; font-family:Times New Roman; font-size:10pt; color:#000000">
<DIV style="width:624px"><P style="margin:0px"><BR>
<BR></P>
<TABLE style="font-size:10pt" cellspacing=0><TR height=0 style="font-size:0"><TD width=177.133></TD></TR>
<TR><TD style="border-left:1px solid #000000; border-top:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" width=177.133><P style="line-height:13pt; margin:0px; font-size:11pt">OMB APPROVAL </P>
</TD></TR>
<TR><TD style="border-left:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=177.133><P style="line-height:13pt; margin:0px; font-size:11pt">OMB Number: 3235-0060 Expires: February 28, 2013 Estimated average burden hours per response........5.00 </P>
</TD></TR>
</TABLE>
<P style="margin-top:0px; margin-bottom:12.667px" align=center><BR></P>
<P style="margin-top:0px; margin-bottom:12.667px" align=center><BR></P>
<P style="margin-top:0px; margin-bottom:12.667px; padding-left:240px; font-size:11pt"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;UNITED STATES </B></P>
<P style="margin-top:0px; margin-bottom:12.667px; padding-left:144px; font-size:11pt" align=center><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECURITIES AND EXCHANGE COMMISSION </B></P>
<P style="margin-top:0px; margin-bottom:12.667px; font-size:11pt" align=center><B>Washington, D.C. 20549 </B></P>
<P style="line-height:13pt; margin:0px; font-size:11pt">&nbsp;</P>
<P style="line-height:13pt; margin-top:0px; margin-bottom:11.467px; font-size:11pt" align=center><B>FORM 8-K </B></P>
<P style="line-height:14.4pt; margin-top:0px; margin-bottom:33.667px; font-size:11pt" align=center><B>CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 </B></P>
<P style="line-height:13pt; margin:0px; font-size:11pt">Date of Report (Date of earliest event reported): </P>
<P style="margin:0px"><BR></P>
<P style="line-height:13pt; margin:0px; font-size:11pt">________<U>July 27, 2014</U>___________________</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px" align=center><BR></P>
<TABLE style="font-size:10pt" cellspacing=0 align=center><TR height=0 style="font-size:0"><TD width=638.4></TD></TR>
<TR><TD valign=top width=638.4><P style="line-height:22pt; margin:0px; font-size:20pt" align=center><B>BIOCUBE, INC.</B></P>
</TD></TR>
</TABLE>
<P style="line-height:13pt; margin:0px; font-size:11pt" align=center>&nbsp;(Exact name of registrant as specified in its charter)</P>
<P style="margin:0px"><BR></P>
<P style="line-height:13pt; margin:0px; font-size:11pt" align=center><B><U>DELAWARE</U></B></P>
<P style="line-height:13pt; margin:0px; font-size:11pt" align=center>State or Other Jurisdiction of Incorporation</P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center><BR></P>
<P style="line-height:13pt; margin-top:0px; margin-bottom:-17.333px; padding-left:48px; text-indent:48px; font-size:11pt"><B><U>333-137920</U></B></P>
<P style="line-height:13pt; margin:0px; padding-left:48px; text-indent:384px; font-size:11pt"><B><U>20-3547389</U></B></P>
<P style="line-height:13pt; margin-top:0px; margin-bottom:-17.333px; padding-left:48px; font-size:11pt">(Commission File Number) &nbsp;&nbsp;&nbsp;&nbsp;</P>
<P style="line-height:13pt; margin:0px; padding-left:48px; text-indent:336px; font-size:11pt">(IRS Employer Identification Number)</P>
<P style="margin:0px" align=center><BR></P>
<P style="line-height:14pt; margin:0px; font-size:12pt" align=center><B>10 Blackledge Court</B></P>
<P style="line-height:14pt; margin:0px; font-size:12pt" align=center><B>Closter, NJ 07624</B></P>
<P style="line-height:14pt; margin:0px; font-size:12pt" align=center>(Address of principal executive offices, zip code)</P>
<P style="margin:0px" align=center><BR></P>
<P style="line-height:14pt; margin:0px; font-size:12pt" align=center><B><U>(201) 750-2001</U></B></P>
<P style="line-height:13pt; margin:0px; font-size:11pt" align=center>Registrant&#146;s telephone number, including area code</P>
<P style="margin:0px"><BR></P>
<P style="line-height:13pt; margin:0px; font-size:11pt">_________________________________________________________________________________ </P>
<P style="line-height:13pt; margin:0px; font-size:11pt" align=center>(Former name or former address, if changed since last report.)</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin-top:0px; margin-bottom:12.667px; font-size:11pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<U>see </U>General Instruction A.2. below): </P>
<P style="margin-top:0px; margin-bottom:12.667px; font-size:11pt">[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </P>
<P style="margin-top:0px; margin-bottom:12.667px; font-size:11pt">[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </P>
<P style="margin-top:0px; margin-bottom:12.667px"><BR>
<BR></P>
<P style="margin-top:0px; margin-bottom:12.667px; font-size:11pt; page-break-before:always">[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </P>
<P style="line-height:14.65pt; margin-top:0px; margin-bottom:12.2px; font-size:11pt">[ ] Pre commencement communications pursuant to Rule 13e 4(c) under the Exchange Act (17 CFR 240.13e 4(c))</P>
<TABLE style="font-size:10pt" cellspacing=0><TR height=0 style="font-size:0"><TD width=97.6></TD><TD width=32.533></TD><TD width=520.533></TD></TR>
<TR><TD style="background-color:#FFFFFF" valign=top width=97.6><P>&nbsp;</P></TD><TD style="background-color:#FFFFFF" valign=top width=32.533><P>&nbsp;</P></TD><TD style="background-color:#FFFFFF" valign=top width=520.533><P>&nbsp;</P></TD></TR>
<TR><TD style="background-color:#FFFFFF" valign=top width=97.6><P>&nbsp;</P></TD><TD style="background-color:#FFFFFF" valign=top width=32.533><P>&nbsp;</P></TD><TD style="background-color:#FFFFFF" valign=top width=520.533><P>&nbsp;</P></TD></TR>
</TABLE>
<P style="margin-top:0px; margin-bottom:12.2px"><BR></P>
<P style="line-height:13pt; margin-top:0px; margin-bottom:-17.333px; font-size:11pt"><B>Section 1 </B></P>
<P style="line-height:14.65pt; margin-top:0px; margin-bottom:12.2px; text-indent:144px; font-size:11pt"><B>Registrant&#146;s Business and Operations</B></P>
<P style="line-height:14.65pt; margin-top:0px; margin-bottom:12.2px; font-size:11pt"><B>ITEM 1.01 Entry into a Material Definitive Agreement</B></P>
<P style="line-height:13pt; margin-top:0px; margin-bottom:11.8px; font-size:11pt" align=justify>On July 27, 2014, BioCube, Inc. (the &#147;Company&#148;) entered into an Asset Purchase Agreement with Innovative Holdings, Inc., a New Jersey corporation (&#147;Innovative&#148;), whereby the Company agreed to purchase from Innovative certain assets in exchange for 2,000,000 restricted common shares of the Company and a convertible promissory note in the amount of $25,000 (the &#147;Agreement&#148;). The specific assets related to mobile applications for patients of medical marijuana facilities in Canada and the United States, as follows:</P>
<P style="line-height:14pt; margin-top:0px; margin-bottom:-18.667px; padding-left:48px; text-indent:-24px; font-family:Symbol; font-size:12pt" align=justify>&#183;</P>
<P style="line-height:14pt; margin:0px; padding-left:48px; font-size:12pt" align=justify>Two (2) separate mobile applications for providing medical marijuana patients in legal states within the United States, and through out Canada to locate nearby doctors, dispensaries and rate and review strains with a touch of your finger. The US based app also provides state-by-state current legislation, how to qualify for a medical marijuana 10 card and how a patient can take action by contacting their local advocacy group to get involved; &nbsp;</P>
<P style="margin:0px" align=justify><BR></P>
<P style="line-height:14pt; margin-top:0px; margin-bottom:-18.667px; padding-left:48px; text-indent:-24px; font-family:Symbol; font-size:12pt" align=justify>&#183;</P>
<P style="line-height:14pt; margin:0px; padding-left:48px; font-size:12pt" align=justify>All franchises, licenses, permits, consents, authorizations, approvals, and certificates of authority of any administrative or regulatory body found in Innovative&#146;s name;</P>
<P style="margin:0px" align=justify><BR></P>
<P style="line-height:14pt; margin-top:0px; margin-bottom:-18.667px; padding-left:48px; text-indent:-24px; font-family:Symbol; font-size:12pt" align=justify>&#183;</P>
<P style="line-height:14pt; margin:0px; padding-left:48px; font-size:12pt" align=justify>All proprietary rights, proprietary knowledge, know-how, designs, processes, trademarks and copyrights which Innovative owns or has a right to use in the operation of its business and all filings, registrations or issuances of any the foregoing with or by any federal, state, local or foreign regulatory, administrative or governmental office in connection therewith; and</P>
<P style="margin:0px" align=justify><BR></P>
<P style="line-height:14pt; margin-top:0px; margin-bottom:-18.667px; padding-left:48px; text-indent:-24px; font-family:Symbol; font-size:12pt" align=justify>&#183;</P>
<P style="line-height:14pt; margin:0px; padding-left:48px; font-size:12pt" align=justify>All other contracts, and other agreements, contract rights, purchase orders, policies and understandings, whether oral or written, to which the Innovative is a party, and used in conducting the business and operations of the Innovative.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="line-height:14pt; margin:0px; font-size:12pt" align=justify>Per the terms of the Agreement, the Company did not assume any of the debts and/or liabilities of Innovative attached to the Assets. &nbsp;Based upon the quoted market price at the time of the execution of the Agreement, the aggregate purchase price is approximately $45,000.00. &nbsp;As a result of the Agreement, the Company owns informational software through mobile applications. </P>
<P style="margin:0px" align=justify><BR>
<BR></P>
<P style="line-height:14pt; margin:0px; font-size:12pt; page-break-before:always" align=justify>Although the purchased Assets do provide real data on medical marijuana, the applications in no way, in no capacity facilitate any sale or trafficking of medical or recreational marijuana. &nbsp;</P>
<P style="margin:0px" align=justify><BR></P>
<P style="line-height:14pt; margin:0px; font-size:12pt" align=justify>The Agreement was executed as an arm&#146;s length transaction and involved no related party.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="line-height:14pt; margin-top:0px; margin-bottom:-18.667px; font-size:12pt" align=justify><B>Section 9</B></P>
<P style="line-height:14pt; margin:0px; text-indent:144px; font-size:12pt" align=justify><B>Financial Statements and Exhibits</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="line-height:14pt; margin-top:0px; margin-bottom:-18.667px; font-size:12pt" align=justify><B>ITEM 9.01</B></P>
<P style="line-height:14pt; margin:0px; text-indent:144px; font-size:12pt" align=justify><B>Financial Statements and Exhibits</B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="line-height:14pt; margin-top:0px; margin-bottom:-18.667px; font-size:12pt; color:#FFFF00" align=justify><A HREF="innovativeagreement.htm"><I><U>10.1</U></I></A><FONT style="color:#000000"></FONT></P>
<P style="line-height:14pt; margin:0px; text-indent:144px; font-size:12pt" align=justify><I>Asset Purchase Agreement dated July 27, 2014</I></P>
<P style="margin:0px"><BR></P>
<P style="line-height:13pt; margin-top:0px; margin-bottom:11.8px; font-size:11pt" align=center><B>SIGNATURES </B></P>
<P style="line-height:13pt; margin:0px; font-size:11pt" align=justify>Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. </P>
<P style="line-height:13pt; margin:0px; font-size:11pt" align=justify>&nbsp;&nbsp;</P>
<P style="margin:0px" align=justify><BR></P>
<P style="line-height:13pt; margin:0px; padding-left:336px; text-indent:48px; font-size:11pt" align=justify><B>BIOCUBE, INC. </B></P>
<P style="line-height:13pt; margin:0px; text-indent:48px; font-size:11pt" align=justify>&nbsp;&nbsp;</P>
<P style="line-height:13pt; margin-top:0px; margin-bottom:-17.333px; font-size:11pt" align=justify>Date: July <A NAME="_GoBack"></A>30, 2014</P>
<P style="line-height:13pt; margin:0px; text-indent:384px; font-size:11pt" align=justify><U>/s/ Boris Rubizhevsky &nbsp;&nbsp;&nbsp;&nbsp;</U></P>
<P style="line-height:13pt; margin:0px; text-indent:384px; font-size:11pt" align=justify>Boris Rubizhevsky &nbsp;&nbsp;&nbsp;&nbsp;</P>
<P style="line-height:13pt; margin:0px; padding-left:384px; font-size:11pt" align=justify>Chief Executive and Financial Officer</P>
<P style="margin:0px" align=justify><BR>
<BR></P>
</DIV></BODY>
<!-- EDGAR Validation Code: 5A3FED9E -->
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "bioinnov8kjuly302014.htm", "secsgml_size_bytes": 13408}]
{"company-data": {"conformed-name": "BioCube, INC.", "cik": "0001374135", "assigned-sic": "4522", "irs-number": "203547389", "state-of-incorporation": "DE", "fiscal-year-end": "0131"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-35227", "film-number": "141004269"}, "business-address": {"street1": "10 BLACKLEDGE COURT", "city": "CLOSTER", "state": "NJ", "zip": "07624", "phone": "201-750-2001"}, "mail-address": {"street1": "10 BLACKLEDGE COURT", "city": "CLOSTER", "state": "NJ", "zip": "07624"}, "former-company": [{"former-conformed-name": "ALLIANCE NETWORK COMMUNICATIONS HOLDINGS, INC.", "date-changed": "20090827"}, {"former-conformed-name": "Halcyon Jets Holdings, Inc.", "date-changed": "20070823"}, {"former-conformed-name": "GREENLEAF FOREST PRODUCTS, INC.", "date-changed": "20060829"}]}
Converted by EDGARwiz
OMB APPROVAL
OMB Number: 3235-0060 Expires: February 28, 2013 Estimated average burden hours per response........5.00
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
________
July 27, 2014
___________________
BIOCUBE, INC.
(Exact name of registrant as specified in its charter)
DELAWARE
State or Other Jurisdiction of Incorporation
333-137920
20-3547389
(Commission File Number)
(IRS Employer Identification Number)
10 Blackledge Court
Closter, NJ 07624
(Address of principal executive offices, zip code)
(201) 750-2001
Registrant's telephone number, including area code
_________________________________________________________________________________
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (
see
General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre commencement communications pursuant to Rule 13e 4(c) under the Exchange Act (17 CFR 240.13e 4(c))
Section 1
Registrant's Business and Operations
ITEM 1.01 Entry into a Material Definitive Agreement
On July 27, 2014, BioCube, Inc. (the "Company") entered into an Asset Purchase Agreement with Innovative Holdings, Inc., a New Jersey corporation ("Innovative"), whereby the Company agreed to purchase from Innovative certain assets in exchange for 2,000,000 restricted common shares of the Company and a convertible promissory note in the amount of $25,000 (the "Agreement"). The specific assets related to mobile applications for patients of medical marijuana facilities in Canada and the United States, as follows:
·
Two (2) separate mobile applications for providing medical marijuana patients in legal states within the United States, and through out Canada to locate nearby doctors, dispensaries and rate and review strains with a touch of your finger. The US based app also provides state-by-state current legislation, how to qualify for a medical marijuana 10 card and how a patient can take action by contacting their local advocacy group to get involved;
·
All franchises, licenses, permits, consents, authorizations, approvals, and certificates of authority of any administrative or regulatory body found in Innovative's name;
·
All proprietary rights, proprietary knowledge, know-how, designs, processes, trademarks and copyrights which Innovative owns or has a right to use in the operation of its business and all filings, registrations or issuances of any the foregoing with or by any federal, state, local or foreign regulatory, administrative or governmental office in connection therewith; and
·
All other contracts, and other agreements, contract rights, purchase orders, policies and understandings, whether oral or written, to which the Innovative is a party, and used in conducting the business and operations of the Innovative.
Per the terms of the Agreement, the Company did not assume any of the debts and/or liabilities of Innovative attached to the Assets.  Based upon the quoted market price at the time of the execution of the Agreement, the aggregate purchase price is approximately $45,000.00.  As a result of the Agreement, the Company owns informational software through mobile applications.
Although the purchased Assets do provide real data on medical marijuana, the applications in no way, in no capacity facilitate any sale or trafficking of medical or recreational marijuana.
The Agreement was executed as an arm's length transaction and involved no related party.
Section 9
Financial Statements and Exhibits
ITEM 9.01
Financial Statements and Exhibits
10.1
Asset Purchase Agreement dated July 27, 2014
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
BIOCUBE, INC.
Date: July
30, 2014
/s/ Boris Rubizhevsky
Boris Rubizhevsky
Chief Executive and Financial Officer